2Canadian Spinal Research organization. Use of 4-aminopyridine in the reduction of chronic pain and spasticity in aspinalcord injured patient: US, 5545648 [P]. 1996-08-13.
3Murray NMF, Newsome-Davis J. Treatment with oral 4-aminopyridine in disorders of neuromuscular transmission [J]. Neurology, 1981, 31(3): 265-271.
5Saurabh KS, Sushant KS. Synthesis and evaluation of some new 4-aminopyridine derivatives as a potent antiamnesic and cognition enhancing drugs [J]. Med Chem Res, 2012, 21(12) : 4395-4402.
6Stork CM, Hoffman RS. Characterization of 4-aminopyradine in overdose [J]. Toxicol Clin Toxicol, 1994, 32(5): 583-587.
7Soriano-Mas C, Redolar-Ripoll D, Aldavert-Vera L, et aL Post-training intracranial self-stimulation facilitates a hippocampus- dependent task [J]. Behav Brain Res. 2005, 160(1):141-147.
8Beilstein F K. Hand buchder organischen chemie [M]. Berlin: Springer-Verlag, 1953: 22: 433.
9Quinn JF, Bryant CE, Golden KC, et aL Rapid reduction of heteroaromatie nitro groups using catalytic transfer hydrogenation with microwave heating [J]. Tetra Lett, 2010, 51(5), 786-789.
10Garcia, JE and Guzman, RZ. Catalytic Transfer Hydrogenation of Bifunctional Poly (ethylene glycol) Derivatives Using Palladium-Poly(ethylenimine) Catalyst [J]. J Org Chem, 1997, 62(25): 8910-8910.
